@OncoLucus @mlazqui cabozantinib no sólo actúa como inhibidor de angiogénesis sino que además potencia la respuesta inmunitaria frente a células de cáncer renal metastásico?
4,617 followers
495 followers
Check out new research from our #RCC feed! “Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity,” from @FrontiersIn https://t.co/D4RQncAwid Enjoy more curated content on #Feedkast every day! https:
6,534 followers
New research: Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity: Background Advanced renal cell carcinoma (RCC) has a very dismal prognosis. Cabozantinib, a tyrosine kinase inhibitor,… https://t.